Mustang Bio’s MB-101 Receives FDA Orphan Drug Designation for Astrocytomas and Glioblastoma Read more
Jazz Pharmaceuticals Gets EU Approval for Ziihera to Treat Advanced HER2-Positive Biliary Tract Cancer Read more
FDA Grants Accelerated Approval to ZEGFROVY, First Oral EGFR‑Exon‑20 Insertion NSCLC Therapy Read more
Lynozyfic (linvoseltamab-gcpt) Granted FDA Accelerated Approval for Relapsed/Refractory Multiple Myeloma Read more